[1] |
Christiansen ME, Detti L. Clinically relevant female genital tract anomalies[J]. Clin Obstet Gynecol, 2017, 60(1): 18-26. DOI: 10.1097/GRF.0000000000000258.
|
[2] |
Passos IMPE, Britto RL. Diagnosis and treatment of müllerian malformations[J]. Taiwan J Obstet Gynecol, 2020, 59(2): 183-188. DOI: 10.1016/j.tjog.2020.01.003.
|
[3] |
|
[4] |
Cahen-Peretz A, Sheiner E, Friger M, et al. The association between Müllerian anomalies and perinatal outcome[J]. J Matern Fetal Neonatal Med, 2019, 32(1): 51-57. DOI: 10.1080/14767058.2017.1370703.
|
[5] |
Fox NS, Roman AS, Stern EM, et al. Type of congenital uterine anomaly and adverse pregnancy outcomes[J]. J Matern Fetal Neonatal Med, 2014, 27(9): 949-953. DOI: 10.3109/14767058.2013.847082.
|
[6] |
Letterie GS. Management of congenital uterine abnormalities[J]. Reprod Biomed Online, 2011, 23(1): 40-52. DOI: 10.1016/j.rbmo.2011.02.008.
|
[7] |
Prior M, Richardson A, Asif S, et al. Outcome of assisted reproduction in women with congenital uterine anomalies: a prospective observational study[J]. Ultrasound Obstet Gynecol, 2018, 51(1): 110-117. DOI: 10.1002/uog.18935.
|
[8] |
Grimbizis GF, Di Spiezio Sardo A, Saravelos SH, et al. The Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies[J]. Hum Reprod, 2016, 31(1): 2-7. DOI: 10.1093/humrep/dev264.
|
[9] |
|
[10] |
Knez J, Saridogan E, Van Den Bosch T, et al. ESHRE/ESGE female genital tract anomalies classification system-the potential impact of discarding arcuate uterus on clinical practice[J]. Hum Reprod, 2018, 33(4): 600-606. DOI: 10.1093/humrep/dey043.
|
[11] |
Makrigiannakis A. Implantation in women with uterine congenital malformations[M]// Grimbizis GF, Campo R, Tarlatzis BC, et al. Female genital tract congenital malformations: classification, diagnosis and management. London: Springer, 2015: 29-34. DOI: 10.1007/978-1-4471-5146-3.
|
[12] |
Cahen-Peretz A, Walfisch A, Friger M, et a1. Maternal müllerian anomalies and future health of the offspring[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 212: 20-24. DOI: 10.1016/j.ejogrb.2017.02.010.
|
[13] |
曹泽毅. 中华妇产科学[M]. 2版. 北京: 人民卫生出版社, 2004: 706-708.
|
[14] |
Chan YY, Jayaprakasan K, Zamora J, et al. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review[J]. Hum Reprod Update, 2011, 17(6): 761-771. DOI: 10.1093/humupd/dmr028.
|
[15] |
Olpin JD, Moeni A, Willmore RJ, et a1. MR imaging of Müllerian fusion anomalies[J]. Magn Reson Imaging Clin N Am, 2017, 25(3): 563-575. DOI: 10.1016/j.mric.2017.03.008.
|
[16] |
Grimbizis GF, Di Spiezio Sardo A, Saravelos SH, et al. The Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies[J]. Gynecol Surg, 2016, 13: 1-16. DOI: 10.1007/s10397-015-0909-1.
|
[17] |
|
[18] |
Pan HX, Liu P, Duan H, et al. Using 3D MRI can potentially enhance the ability of trained surgeons to more precisely diagnose Mullerian duct anomalies compared to MR alone[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 228: 313-318. DOI: 10.1016/j.ejogrb.2018.07.007.
|
[19] |
El Hachem H, Crepaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives[J]. Int J Womens Health, 2017, 9: 331-345. DOI: 10.2147/IJWH.S100817.
|
[20] |
Saravelos SH, Cocksedge KA, Li TC. The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage[J]. Reprod Biomed Online, 2010, 20(3): 416-422. DOI: 10.1016/j.rbmo.2009.11.021.
|
[21] |
Zhou H, Liu Y, Liu L, et al. Maternal pre-pregnancy risk factors for miscarriage from a prevention perspective: a cohort study in China[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 206: 57-63. DOI: 10.1016/j.ejogrb.2016.07.514.
|
[22] |
Jones RK, Jerman J. Population group abortion rates and lifetime incidence of abortion: United States, 2008-2014[J]. Am J Public Health, 2017, 107(12): 1904-1909. DOI: 10.2105/AJPH.2017.304042.
|
[23] |
Hiersch L, Yeoshoua E, Miremberg H, et al. The association between Mullerian anomalies and short-term pregnancy outcome[J]. J Matern Fetal Neonatal Med, 2016, 29(16): 2573-2578. DOI: 10.3109/14767058.2015.1098613.
|
[24] |
Takami M, Aoki S, Kurasawa K, et al. A classification of congenital uterine anomalies predicting pregnancy outcomes[J]. Acta Obstet Gynecol Scand, 2014, 93(7): 691-697. DOI: 10.1111/aogs.12400.
|
[25] |
Venetis CA, Papadopoulos SP, Campo R, et al. Clinical implications of congenital uterine anomalies: a Meta-analysis of comparative studies[J]. Reprod Biomed Online, 2014, 29(6): 665-683. DOI: 10.1016/j.rbmo.2014.09.006.
|
[26] |
Karami M, Jenabi E. The association between Mullerian anomalies and IUGR: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32(14): 2408-2411. DOI: 10.1080/14767058.2018.1432588.
|
[27] |
Khazaei S, Jenabi E, Veisani Y. The association of Mullerian anomalies and placenta abruption: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32(3): 512-516. DOI: 10.1080/14767058.2017.1379072.
|
[28] |
Kroener L, Wang ET, Pisarska MD. Predisposing factors to abnormal first trimester placentation and the impact on fetal outcomes[J]. Semin Reprod Med, 2016, 34(1): 27-35. DOI: 10.1055/s-0035-1570029.
|
[29] |
Shim S, Hur YM, Kim DH, et al. Evidence for no significant impact of Müllerian anomalies on reproductive outcomes of twin pregnancy in Korean women[J]. Twin Res Hum Genet, 2016, 19(2): 146-153. DOI: 10.1017/thg.2016.4.
|
[30] |
DI Spiezio Sardo A, Spinelli M, DA Cunha Vieira M, et a1. Hysteroscopic treatment of Müllerian duct anomalies[J]. Minerva Ginecol, 2016, 68(2): 175-185.
|
[31] |
Budden A, Abbott JA. The diagnosis and surgical approach of uterine septa[J]. J Minim Invasive Gynecol, 2018, 25(2): 209-217. DOI: 10.1016/j.jmig.2017.07.017.
|